Acute leukemia: a pediatric perspective (Q35033268)

5 August 2017

1 reference

title

Acute leukemia: a pediatric perspective (English)

1 reference

5 August 2017

1 reference

1 reference

James R Downing

1

1 reference

PubMed ID

12498712

5 August 2017

Kevin M Shannon

series ordinal

2

1 reference

5 August 2017

1 December 2002

1 reference

5 August 2017

1 reference

5 August 2017

2

1 reference

5 August 2017

437-445

1 reference

5 August 2017

6

1 reference

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Down syndrome, transient myeloproliferative syndrome, and leukemia: bridging development and neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Leukemic transformation in patients with severe congenital neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Nf1 and Gmcsf interact in myeloid leukemogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Proteins regulating Ras and its relatives

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Perspectives on the development of a molecularly targeted agent

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

In utero rearrangements in the trithorax-related oncogene in infant leukaemias.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Multiple clones with (3;21) translocation in a case of Ph-positive chronic myelogenous leukemia during relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Focus on acute leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Current status of umbilical cord blood hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Biallelic inactivation of BRCA2 in Fanconi anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Additional translocation (8;21)(q22;q22) in a patient with Philadelphia-positive chronic myelogenous leukaemia in the blastic phase

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q)

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Oncogenic transcription factors in the human acute leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

The role of the AML1 transcription factor in leukemogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Focus on embryonal malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Histone deacetylase inhibitors as new cancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Childhood acute lymphoblastic leukaemia--current status and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Philadelphia chromosome-positive acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Core-binding factors in haematopoiesis and leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

The two faces of BRCA2, a FANCtastic discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Molecular pathogenesis of fanconi anemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Pathogenesis and management of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic factors and risk allocation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Prenatal origin of acute lymphoblastic leukaemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

Kostmann syndrome and severe congenital neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900211-8

7 January 2021

10.1016/S1535-6108(02)00211-8

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12498712